Tirschwell & Loewy’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $19.7M | Sell |
754,900
-7,700
| -1% | -$201K | 2.7% | 18 |
|
|
2018
Q4 | $17.6M | Sell |
762,600
-52,750
| -6% | -$1.22M | 2.66% | 21 |
|
|
2018
Q3 | $19.2M | Buy |
815,350
+460
| +0.1% | +$10.8K | 2.4% | 19 |
|
|
2018
Q2 | $18.8M | Buy |
814,890
+2,900
| +0.4% | +$66.9K | 2.5% | 17 |
|
|
2018
Q1 | $20M | Sell |
811,990
-970
| -0.1% | -$23.9K | 2.75% | 17 |
|
|
2017
Q4 | $21.8M | Sell |
812,960
-14,970
| -2% | -$402K | 3.08% | 14 |
|
|
2017
Q3 | $19.9M | Buy |
827,930
+8,090
| +1% | +$195K | 3.01% | 14 |
|
|
2017
Q2 | $17.6M | Buy |
819,840
+7,450
| +0.9% | +$160K | 2.76% | 16 |
|
|
2017
Q1 | $13.9M | Buy |
812,390
+11,600
| +1% | +$199K | 2.25% | 17 |
|
|
2016
Q4 | $14.4M | Buy |
800,790
+18,850
| +2% | +$338K | 2.57% | 17 |
|
|
2016
Q3 | $16.3M | Buy |
781,940
+17,190
| +2% | +$357K | 2.7% | 15 |
|
|
2016
Q2 | $20.6M | Sell |
764,750
-16,400
| -2% | -$441K | 3.6% | 7 |
|
|
2016
Q1 | $21.2M | Sell |
781,150
-13,310
| -2% | -$361K | 3.7% | 6 |
|
|
2015
Q4 | $23.1M | Sell |
794,460
-1,800
| -0.2% | -$52.3K | 4.07% | 5 |
|
|
2015
Q3 | $21.6M | Sell |
796,260
-11,450
| -1% | -$311K | 4.07% | 6 |
|
|
2015
Q2 | $22.1M | Sell |
807,710
-7,950
| -1% | -$218K | 3.73% | 5 |
|
|
2015
Q1 | $21.8M | Sell |
815,660
-5,850
| -0.7% | -$156K | 3.63% | 7 |
|
|
2014
Q4 | $17.4M | Buy |
821,510
+7,370
| +0.9% | +$156K | 2.81% | 12 |
|
|
2014
Q3 | $19.4M | Sell |
814,140
-10,300
| -1% | -$245K | 3.24% | 8 |
|
|
2014
Q2 | $19M | Buy |
824,440
+6,060
| +0.7% | +$140K | 3.09% | 10 |
|
|
2014
Q1 | $18.7M | Buy |
818,380
+4,600
| +0.6% | +$105K | 3.21% | 9 |
|
|
2013
Q4 | $15M | Buy |
813,780
+22,200
| +3% | +$410K | 2.61% | 16 |
|
|
2013
Q3 | $13.4M | Buy |
791,580
+65,580
| +9% | +$1.11M | 2.6% | 16 |
|
|
2013
Q2 | $11.3M | Buy |
+726,000
| New | +$11.3M | 2.4% | 16 |
|